See more : Dongguan Eontec Co., Ltd. (300328.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Rohto Pharmaceutical Co.,Ltd. (4527.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Rohto Pharmaceutical Co.,Ltd., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Tatva Chintan Pharma Chem Limited (TATVA.NS) Income Statement Analysis – Financial Results
- Ag Growth International Inc. (AGGZF) Income Statement Analysis – Financial Results
- Grown Up Group Investment Holdings Limited (1842.HK) Income Statement Analysis – Financial Results
- Trade Window Holdings Limited (TWL.NZ) Income Statement Analysis – Financial Results
- Citadel Realty and Developers Limited (CITADEL.BO) Income Statement Analysis – Financial Results
Rohto Pharmaceutical Co.,Ltd. (4527.T)
About Rohto Pharmaceutical Co.,Ltd.
Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin; medicine for internal use, such as digestive and herbal medicines; oral medicines comprising gastrointestinal medicines, herbal medicines, and supplements; non-prescription medicines; and beauty counters that provide beauty and health services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 270.84B | 238.66B | 199.65B | 181.05B | 188.38B | 183.67B | 171.80B | 154.60B | 166.48B | 151.99B | 144.08B | 128.67B | 120.42B | 115.26B | 113.43B | 110.60B | 108.21B |
| Cost of Revenue | 113.55B | 101.24B | 83.16B | 74.33B | 74.14B | 74.05B | 70.75B | 63.25B | 67.25B | 61.40B | 57.92B | 52.79B | 49.93B | 47.32B | 46.65B | 45.40B | 43.52B |
| Gross Profit | 157.29B | 137.42B | 116.49B | 106.73B | 114.24B | 109.62B | 101.05B | 91.35B | 99.23B | 90.60B | 86.16B | 75.87B | 70.50B | 67.94B | 66.78B | 65.20B | 64.68B |
| Gross Profit Ratio | 58.07% | 57.58% | 58.35% | 58.95% | 60.64% | 59.68% | 58.82% | 59.09% | 59.60% | 59.61% | 59.80% | 58.97% | 58.54% | 58.94% | 58.87% | 58.95% | 59.78% |
| Research & Development | 11.80B | 11.07B | 8.74B | 7.90B | 7.05B | 6.83B | 6.55B | 6.12B | 5.81B | 5.59B | 4.55B | 4.06B | 3.72B | 3.70B | 3.73B | 3.74B | 3.80B |
| General & Administrative | 47.09B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 907.00M | 926.00M | 853.00M | 850.00M | 909.00M |
| Selling & Marketing | 54.22B | 46.47B | 38.11B | 40.53B | 47.93B | 47.68B | 44.85B | 40.87B | 47.99B | 44.66B | 40.25B | 35.23B | 32.91B | 31.17B | 30.34B | 29.39B | 29.25B |
| SG&A | 101.31B | 46.47B | 38.11B | 40.53B | 47.93B | 47.68B | 44.85B | 40.87B | 47.99B | 44.66B | 40.25B | 35.23B | 33.82B | 32.09B | 31.19B | 30.24B | 30.16B |
| Other Expenses | 4.14B | -63.00M | 246.00M | 260.00M | -33.00M | -40.00M | 100.00M | 203.00M | -119.00M | 301.00M | 3.00M | 161.00M | 384.00M | 364.00M | 249.00M | 330.00M | -282.00M |
| Operating Expenses | 117.24B | 103.46B | 87.14B | 83.73B | 91.68B | 88.81B | 81.96B | 75.89B | 83.54B | 77.43B | 69.33B | 61.49B | 46.03B | 44.15B | 44.16B | 43.36B | 41.63B |
| Cost & Expenses | 230.79B | 204.70B | 170.29B | 158.06B | 165.81B | 162.86B | 152.71B | 139.14B | 150.79B | 138.83B | 127.25B | 114.28B | 95.96B | 91.47B | 90.81B | 88.76B | 85.15B |
| Interest Income | 1.52B | 962.00M | 368.00M | 341.00M | 484.00M | 377.00M | 354.00M | 208.00M | 264.00M | 249.00M | 230.00M | 129.00M | 96.00M | 61.00M | 64.00M | 95.00M | 147.00M |
| Interest Expense | 196.00M | 247.00M | 248.00M | 145.00M | 125.00M | 148.00M | 143.00M | 135.00M | 166.00M | 231.00M | 165.00M | 180.00M | 223.00M | 353.00M | 359.00M | 473.00M | 587.00M |
| Depreciation & Amortization | 8.69B | 7.80B | 7.69B | 6.75B | 6.94B | 6.40B | 5.91B | 5.92B | 6.45B | 6.34B | 5.93B | 5.45B | 5.14B | 4.46B | 5.57B | 5.69B | 4.41B |
| EBITDA | 50.40B | 41.34B | 35.81B | 28.62B | 29.82B | 27.22B | 25.00B | 21.38B | 22.13B | 19.50B | 22.75B | 19.26B | 19.45B | 18.24B | 18.34B | 15.41B | 17.37B |
| EBITDA Ratio | 18.61% | 18.14% | 19.12% | 17.58% | 15.53% | 13.89% | 14.50% | 14.24% | 13.19% | 13.53% | 16.18% | 15.90% | 24.78% | 24.97% | 25.23% | 24.94% | 25.28% |
| Operating Income | 40.05B | 33.96B | 29.35B | 22.99B | 23.09B | 20.81B | 19.09B | 15.45B | 15.68B | 13.16B | 16.82B | 14.38B | 13.62B | 13.11B | 12.54B | 11.64B | 13.04B |
| Operating Income Ratio | 14.79% | 14.23% | 14.70% | 12.70% | 12.25% | 11.33% | 11.11% | 9.99% | 9.42% | 8.66% | 11.67% | 11.18% | 11.31% | 11.37% | 11.06% | 10.52% | 12.05% |
| Total Other Income/Expenses | 1.47B | 331.00M | -1.14B | 16.00M | -1.36B | -4.51B | -2.27B | -699.00M | -1.38B | 592.00M | -2.22B | -750.00M | 464.00M | 325.00M | -132.00M | -2.39B | -669.00M |
| Income Before Tax | 41.52B | 34.29B | 27.95B | 23.01B | 21.73B | 16.30B | 16.82B | 14.75B | 14.30B | 13.75B | 14.60B | 13.63B | 14.09B | 13.43B | 12.41B | 9.24B | 12.37B |
| Income Before Tax Ratio | 15.33% | 14.37% | 14.00% | 12.71% | 11.54% | 8.87% | 9.79% | 9.54% | 8.59% | 9.05% | 10.13% | 10.59% | 11.70% | 11.65% | 10.94% | 8.36% | 11.43% |
| Income Tax Expense | 10.12B | 7.86B | 6.80B | 6.24B | 6.45B | 6.48B | 7.48B | 4.74B | 5.22B | 5.12B | 5.65B | 5.53B | 5.94B | 5.49B | 4.64B | 3.10B | 4.85B |
| Net Income | 30.94B | 26.38B | 21.13B | 16.74B | 15.41B | 9.80B | 9.29B | 10.01B | 9.10B | 8.63B | 8.95B | 8.09B | 8.18B | 7.97B | 7.77B | 6.14B | 7.53B |
| Net Income Ratio | 11.42% | 11.05% | 10.58% | 9.25% | 8.18% | 5.34% | 5.41% | 6.48% | 5.47% | 5.68% | 6.21% | 6.29% | 6.80% | 6.91% | 6.85% | 5.55% | 6.95% |
| EPS | 135.60 | 115.62 | 92.61 | 73.39 | 67.56 | 43.00 | 40.77 | 43.98 | 40.02 | 38.03 | 38.58 | 34.39 | 34.80 | 33.88 | 33.03 | 26.21 | 32.55 |
| EPS Diluted | 135.21 | 115.29 | 92.34 | 73.18 | 67.36 | 42.83 | 40.60 | 43.79 | 39.85 | 37.87 | 38.41 | 34.24 | 34.66 | 33.73 | 32.89 | 26.04 | 31.98 |
| Weighted Avg Shares Out | 228.14M | 228.14M | 228.14M | 228.14M | 228.08M | 227.91M | 227.83M | 227.67M | 227.34M | 226.98M | 231.19M | 231.19M | 231.19M | 231.19M | 231.19M | 231.19M | 231.19M |
| Weighted Avg Shares Out (Dil) | 228.80M | 228.80M | 228.80M | 228.80M | 228.79M | 228.79M | 228.79M | 228.64M | 228.31M | 227.94M | 231.19M | 231.19M | 231.19M | 231.19M | 231.19M | 231.19M | 235.34M |
Source: https://incomestatements.info
Category: Stock Reports